Form 4 for NVAX NOVAVAX INC
Accepted 2022-06-21 00:00:00 ET · period of report 2022-06-17 · accession 0001209191-22-038593 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-21 | 2022-06-17 | NVAX | King Rachel K. | Dir | M - OptEx | — | +700 | 6,950 | +11% | — |
| D | 2022-06-21 | 2022-06-17 | NVAX | King Rachel K. | Dir | M - OptEx | $0.00 | -700 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-17 | M | A | 700 | — | 6,950 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
| 2 | Derivative | Restricted Stock Units | 2022-06-17 | M | D | 700 | $0.00 | 0 | D | — · — to — | 700 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. (F3) One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 17, 2021 grant date subject to continued service on the Company's Board of Directors through the vesting date. |